reference/30938165

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30938165

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	1380
issn	1347-9032 1349-7006
issueIdentifier	7
pageRange	1374-1380
publicationName	Cancer Science
startingPage	1374
bibliographicCitation	Tian S, Quan H, Xie C, Guo H, Lü F, Xu Y, Li J, Lou L. YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivo. Cancer Science. 2011 May 09;102(7):1374–80. doi: 10.1111/j.1349-7006.2011.01939.x.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_09e9b5f141c33b2fa770e441507fed0e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5fad67654fa0461c7ec1a8b723cd0b56 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_243ceaf0f1fa3ee3bf770261eeefe906 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_316806deed20278ae58dc6d4865b4b28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39de5ad2bcd86ef53584a4bcb216f515 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_06290950baa9f3044e99d004c9723835 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_07772acb7e986f8d926a37d58f65905e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_769e637cc4c526ed0b6dcdb28c0d66b3
date	2011-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/j.1349-7006.2011.01939.x https://pubmed.ncbi.nlm.nih.gov/21443688
isPartOf	https://portal.issn.org/resource/ISSN/1349-7006 https://portal.issn.org/resource/ISSN/1347-9032 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30320
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	YN968D1 is a novel and selective inhibitor of vascular endothelial growth factor receptor‐2 tyrosine kinase with potent activity in vitro and in vivo
discusses	http://id.nlm.nih.gov/mesh/M0551682 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0185196 http://id.nlm.nih.gov/mesh/M0018233
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D040301Q000037 http://id.nlm.nih.gov/mesh/D000970Q000494 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D011725Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D002465Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D017207 http://id.nlm.nih.gov/mesh/D051381 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D049109Q000187
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_714b3f52d8149c3277181d9513b93112 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45139106 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_25d902c24283ab8cfbac54dfa101ad31 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11315474 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cb58e6788fc9a69c674bb00f98bffc14 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8d5493e28bec1e66deda063ef4c39c88

Incoming Links

Predicate	Subject
citesAsDataSource	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223365983_AID1345555_PMID21443688_VALUE28 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223365983_AID1345506_PMID21443688_VALUE31 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223365983_AID1345914_PMID21443688_VALUE9 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID223365983_AID1345614_PMID21443688_VALUE1
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3791 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3815 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1445 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID223365983 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5979

Total number of triples: 65.